Figure 3 from: Alamir HT, Albahadly WK, Al-Zubaidy HFS, Sahib AS, Altrufi MH, Hamza N (2026) Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression. Pharmacia 73: e207442. https://doi.org/10.3897/pharmacia.73.e207442

Hassan Thoulfikar Alamir, Waleed Khaled Albahadly, Haider F. S. Al-Zubaidy, Ahmed Salih Sahib, Meeqaat H. Altrufi, Najah Hamza

Open source

DOI: 10.3897/pharmacia.73.e207442.figure3
Published: 2026-08-28
Container: Not recorded
Publisher: Pensoft Publishers
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3897/pharmacia.73.e207442.figure3,
  title = {Figure 3 from: Alamir HT, Albahadly WK, Al-Zubaidy HFS, Sahib AS, Altrufi MH, Hamza N (2026) Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression. Pharmacia 73: e207442. https://doi.org/10.3897/pharmacia.73.e207442},
  author = {Hassan Thoulfikar Alamir and Waleed Khaled Albahadly and Haider F. S. Al-Zubaidy and Ahmed Salih Sahib and Meeqaat H. Altrufi and Najah Hamza},
  year = {2026},
  doi = {10.3897/pharmacia.73.e207442.figure3},
  url = {https://doi.org/10.3897/pharmacia.73.e207442.figure3}
}

RIS

TY  - JOUR
TI  - Figure 3 from: Alamir HT, Albahadly WK, Al-Zubaidy HFS, Sahib AS, Altrufi MH, Hamza N (2026) Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression. Pharmacia 73: e207442. https://doi.org/10.3897/pharmacia.73.e207442
AU  - Hassan Thoulfikar Alamir
AU  - Waleed Khaled Albahadly
AU  - Haider F. S. Al-Zubaidy
AU  - Ahmed Salih Sahib
AU  - Meeqaat H. Altrufi
AU  - Najah Hamza
PY  - 2026
DO  - 10.3897/pharmacia.73.e207442.figure3
UR  - https://doi.org/10.3897/pharmacia.73.e207442.figure3
ER  -

APA

Alamir, H. T., Albahadly, W. K., Al-Zubaidy, H. F. S., Sahib, A. S., Altrufi, M. H., & Hamza, N. (2026). Figure 3 from: Alamir HT, Albahadly WK, Al-Zubaidy HFS, Sahib AS, Altrufi MH, Hamza N (2026) Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression. Pharmacia 73: e207442. https://doi.org/10.3897/pharmacia.73.e207442. https://doi.org/10.3897/pharmacia.73.e207442.figure3

Source records

crossref · retrieved 2026-09-26T02:50:44.043Z